Liver News and Research

RSS

Shear-thinning biomaterial-based minimally invasive strategy for delivery of targeted immunotherapy

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed and optimized a minimally invasive method for more targeted, efficient, and sustained delivery of immunotherapeutic treatments for cancer.

2 Aug 2022

Carbon monoxide foam in the fight against inflammation

News-Medical speaks to Leo Otterbein about a novel way to deliver carbon monoxide to the body while bypassing its potentially hazardous effects.

2 Aug 2022

What is the safety of Molnupiravir against SARS-CoV-2 in the elderly?

A new study assessed the safety of the oral administration of Molnupiravir to elderly patients––aged 80 or older, hospitalized with COVID-19.

1 Aug 2022

Gene mutation responsible for hereditary hemochromatosis may be a risk factor for movement disorders

A disorder called hereditary hemochromatosis, caused by a gene mutation, results in the body absorbing too much iron, leading to tissue damage and conditions like liver disease, heart problems and diabetes.

1 Aug 2022

NIH updates its strategic plan for hepatitis B research

The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved strategies for vaccination, screening and follow-up care.

1 Aug 2022

NUS study provides evidence of the cytotoxic effect of black cardamom on lung cancer cells

The main challenges associated with existing lung cancer drugs are severe side effects and drug resistance. There is hence a constant need to explore new molecules for improving the survival rate and quality of life of lung cancer patients.

1 Aug 2022

Nutritive intervention could be an effective treatment method in maintaining human health

In a new study, researchers assessed the impact of dietary regulation on human health and disease.

1 Aug 2022

Nanoparticles' toxic effects on macrophages

Researchers summarize the toxic effects of nanoparticles on macrophages in vitro.

31 Jul 2022

Higher insulin dose is positively linked with cancer incidence, study finds

Dr. Yuanjie Mao has led a study published in the Journal of the American Medical Association (JAMA) Oncology looking at the correlation between daily insulin dose and cancer incidence (the number of new cases) among patients with type 1 diabetes, finding that higher insulin dose is positively associated with cancer incidence and that the association is stronger among those with insulin resistance.

29 Jul 2022

Study reveals how barrier cells that line the intestines send messages to patrolling T cells

Cells in the gut send secret messages to the immune system. Thanks to new research from La Jolla Institute for Immunology (LJI) scientists, we can finally get a look at what they're saying.

29 Jul 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

Transplant remains the standard of care for liver cancer patients, regardless of age

Physicians and researchers from UK HealthCare's Transplant Center and the University of Kentucky Markey Cancer Center conducted a study of patients over the age of 70 with a type of liver cancer called hepatocellular carcinoma (HCC) and how the outcomes of ablative treatments compare to liver transplants.

28 Jul 2022

People with unhealthy sleep behaviors could develop fatty liver disease

People with sedentary lifestyles and unhealthy sleep behaviors could develop fatty liver disease, according to new research published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

28 Jul 2022

Researchers find adeno-associated virus 2 infection in children with hepatitis of unknown etiology

Researchers investigated the cases of severe hepatitis of unknown etiology in young children who presented to the hospital between 14 March and 4 April 2022 in Scotland.

28 Jul 2022

Everything you need to know about Paxlovid — especially, should you take it?

When President Joe Biden tested positive for covid-19 on July 21, his physician recommended he take the antiviral drug Paxlovid.

28 Jul 2022

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

In our latest interview, News-Medical speaks to Simon Parker, an infectious disease specialist, about hepatitis C diagnostics and testing, as well as why the global fight against hepatitis cannot wait.

28 Jul 2022

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Researchers estimated the years of life lost during the COVID-19 pandemic in the United States.

28 Jul 2022

Lactating mice expose their feeding pups to triclosan resulting in early signs of liver damage

In mouse studies, researchers at University of California San Diego School of Medicine report that lactating mothers expose their feeding pups to triclosan, an antimicrobial commonly used in consumer products, resulting in early signs of liver damage that can eventually lead to more serious impairment and illness, such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

28 Jul 2022

'Western style' diet high in fat and sugar can negatively affect breast milk and baby's health

A diet high in sugar and fat such as burgers, fries and fizzy drinks can negatively affect a new mother's breast milk and baby's health even before the child is conceived.

27 Jul 2022

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Researchers assessed the biodistribution and safety of SBCoV202, a novel antiviral agent based on antisense technology that can specifically and effectively bind to the SARS-CoV-2 genome target to inhibit SARS-CoV-2 replication.

27 Jul 2022

Liver News and Research

Shear-thinning biomaterial-based minimally invasive strategy for delivery of targeted immunotherapy

Carbon monoxide foam in the fight against inflammation

What is the safety of Molnupiravir against SARS-CoV-2 in the elderly?

Gene mutation responsible for hereditary hemochromatosis may be a risk factor for movement disorders

NIH updates its strategic plan for hepatitis B research

NUS study provides evidence of the cytotoxic effect of black cardamom on lung cancer cells

Nutritive intervention could be an effective treatment method in maintaining human health

Nanoparticles' toxic effects on macrophages

Higher insulin dose is positively linked with cancer incidence, study finds

Study reveals how barrier cells that line the intestines send messages to patrolling T cells

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Transplant remains the standard of care for liver cancer patients, regardless of age

People with unhealthy sleep behaviors could develop fatty liver disease

Researchers find adeno-associated virus 2 infection in children with hepatitis of unknown etiology

Everything you need to know about Paxlovid — especially, should you take it?

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

Years of life lost associated with leading causes of US death during the first 20 months of the COVID-19 pandemic

Lactating mice expose their feeding pups to triclosan resulting in early signs of liver damage

'Western style' diet high in fat and sugar can negatively affect breast milk and baby's health

Novel compound inhibits SARS-CoV-2 replication by binding a genome target

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News